🚨 Read our 5 most popular articles from this week 🚨 1. hubs.li/Q03GfY9f0 2. hubs.li/Q03GfVGq0 3. hubs.li/Q03GfZ7G0 4. hubs.li/Q03GfTfC0 5. hubs.li/Q03GfZqw0 #pancsm #crcsm #bcsm #blcsm #mmsm

Surprising Benefits of Adjuvant Abemaciclib in Breast Cancer Treatment oncodaily.com/science/adjuva… Jason A. Mouabbi MD Sara Tolaney #Immunotherapy #CancerTreatment #BreastCancer #BCSM #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

It's time for the #FiveUnder5 🕓! Watch the top 5⃣ #oncology videos of the week 🎥 featuring experts from Atrium Health Wake Forest University School of Medicine Dana-Farber Harvard Medical School City of Hope Penn Medicine: onclive.com/view/five-unde… #lcsm #gyncsm #bcsm #pcsm #medtwitter

WATCH: Jason A. Mouabbi MD of MD Anderson Cancer Center discusses discusses unmet needs and areas requiring further investigation in HER2+ advanced breast cancer. 📺 onclive.com/view/dr-mouabb… #bcsm #oncology

Researchers assessed the risk of subsequent ipsilateral invasive breast cancer in women with ductal carcinoma in situ (DCIS) who received no surgery or radiation within 6 months of diagnosis. jwat.ch/4lLaxMl #dcis #bcsm

Practice affirming. Adjuvant capecitabine for residual disease after adjuvant chemo improves outcomes. Reassuring this is true in a real world data set and not just the CREATE-X trial. Interestingly only half receive adjuvant therapy. #bcsm #TNBC esmoopen.com/article/S2059-…

#DoseOptimization in Oncology Drugs - a 🧵 #bcsm 1/ “The modern drug development paradigm in oncology should recognize that the MTD is not necessarily the optimal dose… phase I trials should determine a range of dosages.” —FDA/ASCO guidance (July 2025) 👉 raps.org

It's time for the #OncFive 5️⃣, your go-to source for the top #oncology articles of the week. Learn more about the items that made the list 👉: hubs.ly/Q03GhWVb0 #pcsm #bcsm #lcsm #medtwitter #oncology #WCLC25

Breast cancer weight-loss intervention may help determine if weight loss can reduce recurrence risk Participants lost an average 4.7% of body weight From Jennifer Ligibel, MD, et al Dana-Farber ascopost.com/news/august-20… #lifestylemedicine #cancerresearch #bcsm

Results from monarchE showed a statistically significant OS improvement with abemaciclib plus ET vs ET alone for patients with HR+/HER2– early breast cancer. hubs.li/Q03G5-vV0 #bcsm #oncology #cancer

#FindingsFriday: New analysis of E4112 study data shows race, insurance type, & number of surgeries significantly impact long-term mental & physical health for women with #DCIS. Learn more: bit.ly/3JujV9W #BreastCancer #bcsm

“…safety is the number 1 policy; however, at the same time, when patients are living between life and death, it's important [to have more available treatments].” #Cancer #bcsm #Oncology #Metastatic

Wow 🤩 #bcsm Look fwd to seeing the data as well as for 5yr data for NATALEE #esmo25

The ASCO Post Rima Patel Icahn School of Medicine at Mount Sinai Everolimus shows promise in TNBC with 52% reduced progression risk. mTOR inhibition could be key. Phase III next. #BCSM